TSPO and Alzheimer disease: Thus, capturing the onset of neuroinflammation by live imaging with TSPO radiotracers may make it possible to diagnose AD earlier than by amyloid-PET, thereby expanding the therapeutic window for earlier intervention and providing additional information on the neuropathological mechanisms leading to clinical symptom progression.